Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - European Market Recap: FTSE 100 (0.07%) to 7455.24, DAX +0.16% to 15992.67 , CAC (0.21%) to 7250.13

Nov 28 ,2023

  • Synopsis:

    • European equity markets closed mixed to lower. Portugal +1.1%, Spain and Austria both +0.7% lead outperformers, whilst, Denmark (2.4%), Norway (1.0%) and Sweden (0.6%) lead underperformers.

    • No change in recent market drivers. Equity markets easing after recent strength. Focus still on central bank policy outlook. Policymakers continue to push back on rate cut expectations. ECB's Cos and Nagel said it was too soon to talk about rate cuts. Similar comments from other ECB officials in recent sessions. Lagarde hinted Monday quicker balance sheet runoff. BoE Governor Bailey also said was too premature to talk about rate cuts. Deputy chief Ramsden said rate outlook data dependent although hawk Haskel defended higher-for-longer stance.

    • Elsewhere, Israel-Hamas ceasefire extended by another two days. Some chatter that OPEC+ meeting could be delayed again as talks remain difficult.

    • On the macro-front, German Gfk consumer confidence beat forecast. France's reading via Insee also improved. UK shop price inflation slowed to lowest rate in a year. Industry data shows UK property sellers accepting larger discounts to complete sales. Also, Eurozone Oct M3 Money Supply contracted by a further (1.0%) vs consensus (0.9%) and prior (1.2%)

    • In corporate news, out of the UK, Rolls-Royce Holdings (RR.LN) issued a CMD update, with current trading is in line with expectations and guidance for 2023 being reconfirmed; also it set mid-term targets to deliver record future performance and also announced a group-wide divestment program as well as proposed 2,000-2,500 reduction in roles worldwide; EasyJet (EZJ.LN) reported FY numbers and reinstated dividends whilst local press wrote that Barclays (BARC.LN) is considering dropping thousands of clients at investment bank as part of strategic overhaul. In the DACH region, Novartis (NOVN.SW), upgraded mid-term sales guidance to 5% CAGR (2022-27), whilst ADLER Group (ADJ.GR) posted weaker that expected 9M. In France, ATOS SE (ATO.FP) announced a market update based on recent developments in the media as well as the S&P change ratings; Veolia (VIE.FP) signed agreement to sell the activities of its subsidiary SADE to NGE for €260M and SPIE (SPIE.FP) acquired ROBUR Industry Service Group GmbH in Germany.

    • Looking ahead to next week's calendar (see - Europe Week Ahead: 27-Nov to 1-Dec attached) Prosus (PRX.NA), CA Immobilien Anlagen (CAI.AV), IMMOFINANZ (IIA.AV), Aroundtown (AT1.GR), ADLER Real Estate (ADL.GR), Pennon (PNN.LN), Impax Asset Management (IPX.LN), Halfords (HFD.LN), Norsk Hydro (NHY.NO), Deliveroo (ROO.LN), Acerinox (ACX.SM), Orkla (ORK.NO) and Roche Holding (ROG.SW) will be among other names to update investors, whilst the macro-calendar releases will includeGermany Nov preliminary CPI, Eurozone Nov economic sentiment, UK Oct mortgage approvals, M4 money supply, Sweden Q3 final GDP, Oct trade balance, retail sales, Spain Nov preliminary CPI, Oct retail sales, Italy Nov business/consumer confidence, Switzerland Nov economic sentiment - ZEW, Italy Oct PPI, Belgium Nov CPI, Ireland Nov preliminary HICP

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Utilities +0.65%, Banks +0.39%, Travel & Leisure +0.30%, Energy+0.24%, Ind Goods & Svcs +0.21%, Basic Resources +0.19%, Retail +0.15%, Telecom +0.06%, Construct & Mtls +0.02%, Financial Svcs (0.06%), Insurance (0.21%), Media (0.20%), Technology (0.24%),

      • Underperformers:

        • Health Care (1.40%), Consumer Products and Services (1.32%), Real Estate (0.72%), Food, Beverage and Tobacco (0.66%), Autos & Parts (0.38%), Chemicals (0.35%),

    • Macro/Peripheral markets:

      • Geopolitics

        • OPEC+ Talks Hit Stalemate on Africa Oil-Output Quota Dispute - Bloomberg

        • Israel and Hamas Trade Blame Amid Claims of Truce Violations - Bloomberg

      • EU

        • Mortgage rebound slows pace of eurozone credit contraction - FT

      • UK

        • UK Watchdog Casts Doubt on Sunak Claim He's on Track to Cut Debt - Bloomberg

        • No Prospect UK Rates Will Be Cut Soon, BOE's Haskel Says - Bloomberg

        • Britain's gas storage site begins supplying grid amid cold snap - The Telegraph

        • City minister tells UK regulators to allow more risk-taking - FT

      • Germany

      • France

        • France seeks ban on ultra-right groups in effort to quell racial tensions - FT

      • Finland

        • Finland will close Russian border for 2 weeks to stop asylum seekers - Reuters

      • Netherlands

        • Week after shock Wilders win, Dutch government talks set to begin - Reuters

      • Greece

    • Company news:

      • Trading Higher:

        • +23.4% DPEU.LN (Dp Eurasia £0.85, +0.16) -- 10M trading update; offer from Jubilant FoodWorks to acquire up-to-51.2% remaining stake in the company at up-to-85p/sh

        • +12.7% ANOT.SS (Anoto Group SEK0.27, +0.03) -- $1.1M procurement and software licensing agreement with Deutsche Telekom AG.

        • +9.2% IDEX.NO (IDEX Biometrics NOK0.58, +0.05) -- biometric sensor solutions orders

        • +5.9% RR.LN (Rolls-Royce Holdings £2.57, +0.14) -- looking at options to exit the Rolls-Royce Electrical; proproses staff reduction worldwide; CMD update

        • +5.1% IQG.LN (IQGeo Group £2.68, +0.13) -- to host Capital Markets Day tomorrow

        • +4.2% EZJ.LN (EasyJet £4.23, +0.17) -- FY earnings

        • +3.3% BOOZT.SS (Boozt Fashion SEK119.40, +3.80) -- updates FY guidance; reinitiated hold at SEB

        • +2.8% ORX.SS (Orexo SEK14.86, +0.40) -- New Drug Application filing for OX124 accepted for review by FDA

        • +2.4% ROL.SW (Von Roll Holding CHF0.85, +0.02) -- notes ALTANA AG announces completion of the tender offer and initiates squeeze-out procedure under takeover law

        • +2.1% JSG.LN (Johnson Service Group £1.33, +0.03) -- completes share buyback programme

        • +1.9% PACT.SS (Proact IT Group SEK84.50, +1.60) -- share repurchase program of up to 10% of its total number of outstanding shares

        • +1.8% METN.SW (Metall Zug CHF1,400.00, +25.00) -- form JV with Miele in infection control, life science

      • Trading Lower:

        • -18.7% MRL.LN (Marlowe £4.13, -0.94) -- H1 earnings

        • -11.0% AGAS.NO (Avance Gas Holding NOK156.00, -19.20) -- Q3 earnings

        • -10.0% ARGX.BB (argenx €406.50, -45.60) -- ADVANCE-SC study evaluating VYVGART Hytrulo ails to meet primary, secondary endpoints

        • -8.8% NEL.NO (NEL ASA NOK7.15, -0.69) -- Fearnley downgrade

        • -8.4% UBI.FP (Ubisoft Entertainment €26.90, -2.48) -- places ~ €500M convertible bonds

        • -6.8% ATO.FP (ATOS SE €5.91, -0.43) -- market update

        • -6.7% NKR.NO (Nekkar NOK8.16, -0.59) -- Q3 earnings

        • -5.9% BIOVIC.B.SS (Biovica International SEK2.80, -0.18) -- Q2 earnings

        • -5.5% TRMD.A.DC (TORM Plc DKK202.20, -11.80) -- 2.81M share block being shopped through Morgan Stanley, we're told

        • -5.3% TUNE.LN (Focusrite £4.50, -0.25) -- FY earnings

        • -4.7% GNC.LN (Greencore Group £0.97, -0.05) -- FY earnings, Peel Hunt downgrade

        • -4.7% BAER.SW (Julius Baer Group CHF43.34, -2.15) -- BofA downgrade; Morgan Stanley downgrade

        • -4.7% ADJ.GR (ADLER Group €0.30, -0.02) -- 9M earnings

        • -4.6% EMG.LN (Man Group £2.07, -0.10) -- Morgan Stanley downgrade

        • -3.8% SAGA.LN (Saga Plc £1.20, -0.05) -- CEO steps down

        • -3.5% PSON.LN (Pearson £9.34, -0.34) -- BNP Paribas Exane downgrade

        • -3.4% GBG.LN (GB Group £2.48, -0.09) -- H1 earnings

        • -1.9% SAFE.LN (Safestore Holdings £7.62, -0.15) -- Q4 revenue

    • EU companies reporting tomorrow:

      • Earnings:

        • Benelux: Prosus (PRX.NA)

        • DACHs: CA Immobilien Anlagen (CAI.AV), IMMOFINANZ (IIA.AV), Aroundtown (AT1.GR), ADLER Real Estate (ADL.GR), Novem (NVM.GR), Addex Therapeutics Ltd. (ADXN.SW)

        • France: SII (SII.FP)

        • Nordics: Panoro Energy (PEN.NO), Viaplay Group (VPLAY.A.SS)

        • Southern Europe: AEDAS Homes (AEDAS.SM), Ibersol (IBS.PL)

        • UK: Pennon (PNN.LN), Impax Asset Management (IPX.LN), Halfords (HFD.LN), Benchmark (BMK.LN), Braemar (BMS.LN)

      • Trading Update: Quadient (QDT.FP)

      • CMD/events: Norsk Hydro (NHY.NO), Deliveroo (ROO.LN), Acerinox (ACX.SM), Orkla (ORK.NO), Roche Holding (ROG.SW)

  • Data:

    • Economics:

      • France Nov Consumer Confidence 87 vs consensus 84 and prior 84

      • Germany Dec GfK Consumer Confidence (27.8) vs consensus (27.9) and prior revised to (28.3) from (28.1)

      • Denmark Oct Retail Sales +3.7% y/y vs consensus +3.4% and prior +1.7%

      • Eurozone Oct M3 Money Supply (1.0%) vs consensus (0.9%) and prior (1.2%)

    • Markets:

      • WTI Crude (Jan 24): +$1.85 or +2.47% to $76.71

      • €-$ +0.0038 or +0.35% to 1.0994

      • £-$ +0.0063 or +0.50% to 1.2690

      • €-£ (0.0013) to 0.8663

      • S&P 500 +0.36%

      • Performance year-to-date

        • FTSE 100: +0.05%

        • DAX: +14.86%

        • CAC: +11.99%

        • MIB: +23.83%

        • Stoxx 600: +7.57%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE